24.5.2004: Meldung: Natural Alternatives International Strengthens Product Development
Dr. Kay joins NAI from Anabolic Laboratories, where he was Vice President of Product Development. He also worked at Leiner Health Products where he was Chief Science Officer and developed products for major retailers, wholesalers and pharmaceutical companies. Dr. Kay is a Registered Dietician who earned his Doctoral and Master"s Degrees in Nutrition from the University of Connecticut. He will lead our product development, regulatory affairs and quality assurance teams.
Chairman and CEO Mark LeDoux said, "Bob brings a wealth of knowledge, diverse industry experience and enthusiasm to NAI. We believe that our science and quality teams, under Bob"s leadership, will continue to introduce new innovative products, enhance regulatory compliance capabilities and create business development opportunities as we strengthen our competitive advantages within the nutritional supplement industry."
NAI, headquartered in San Marcos, California, is a leading formulator and manufacturer of nutritional supplements that provides strategic partnering services to its customers. Our comprehensive partnership approach offers a wide range of innovative nutritional products and services to the client including: scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review and international product registration assistance. For more information about NAI, please see our website at http://www.nai-online.com.
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 that are not historical facts and information. These statements represent our intentions, expectations and beliefs concerning future events, including, among other things, our expectations and beliefs with respect to the impact of hiring a new executive. We wish to caution readers that these statements involve risks and uncertainties that could cause actual results and outcomes for future periods to differ materially from any forward-looking statement or views expressed herein. The forward-looking statements contained herein are further qualified by other risks including those set forth from time to time in the documents filed by us with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q.
John R. Reaves, Chief Financial Officer of Natural Alternatives International, Inc., +1-760-744-7340, or firstname.lastname@example.org.